Protocolo de diagnóstico y tratamiento de la valvulopatía mitral

  1. Martí Sánchez, D.
  2. Morales Gallardo, M.J.
  3. Rueda Linares, A.
  4. Gómez Vicente, R.
Zeitschrift:
Medicine: Programa de Formación Médica Continuada Acreditado

ISSN: 0304-5412

Datum der Publikation: 2017

Serie: 12

Nummer: 40

Seiten: 2396-2399

Art: Artikel

DOI: 10.1016/J.MED.2017.09.005 DIALNET GOOGLE SCHOLAR

Andere Publikationen in: Medicine: Programa de Formación Médica Continuada Acreditado

Zusammenfassung

Abstract Mitral valve disease is a major cause of morbidity in clinical practice. Mitral stenosis continues to be very present in the population from less favored areas, and mitral insufficiency is a prevalent pathology in industrialized countries. Transthoracic echocardiography is the mainstay in syndromic diagnosis and severity quantification of valve disease. Transesophageal echocardiography is necessary in many cases to complete the study, define the etiology and plan the best therapeutic option. In cases with favorable anatomy, the treatment of choice of mitral stenosis is percutaneous mitral valvuloplasty. Mitral regurgitation is probably the most treacherous of valve diseases, and premature identification of its hemodynamic repercussion is warranted to achieve the best surgical results.

Bibliographische Referenzen

  • Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf C, Levang OW. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24(13):1231-43.
  • Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esqui-vias G, Baumgartner H. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2012;33(19):2451-96.
  • Ben Farhat M, Ayari M, Maatouk F, Betbout F, Gamra H, Jarra M. Percutaneous balloon versus surgical closed and open mitral commissurotomy: seven year followup results of a randomized trial. Circulation. 1998;97:245-50.
  • Moya JL, Darriba-Pollán J, García-Lledó A, Taboada D, Catalán-Sanz P, Megías-Saez A. Estimación de la severidad de la insuficiencia mitral según un método simplificado basado en el flujo de convergencia proximal. Rev Esp Cardiol. 2006;59(10):1019-25.
  • Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364(15):1395-406.
  • Michler RE, Smith PK, Parides MK, Ailawadi G, Thourani V, Moskowitz AJ. Two year outcomes of surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2016;374(20):1932-41.
  • Lazam S, Vanoverschelde JL, Tribouilloy C, Grigioni F, Suri RM, Avierinos JF. Twenty year outcome after mitral repair versus replacement for severe degenerative mitral regurgitation: analysis of a large, prospective, multicenter, international registry. Circulation. 2017;135(5):410-22.
  • Goldstein D, Moskowitz AJ, Gelijns AC, Ailawadi G, Parides MK, Perrault LP. Two year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. 2016;374(4):344-53.
Fuente de los datos: Dialnet